GenoME Diagnostics closes pre-seed funding round

The Queen’s University Belfast spin-out develops novel blood tests for earlier and more accurate detection of ovarian cancer. The cutting-edge technology can produce cost-effective diagnostics, helping to reduce misdiagnosis and late diagnosis of the disease.

The round was supported by QUBIS, the commercialisation arm of Queen’s University, Deepbridge Capital and Co-Fund NI.

GenoME Diagnostics was created after almost a decade of research by Dr Paul Mullan, Dr James Beirne and Dr Laura Feeney at the Patrick G Johnston Centre for Cancer Research (PGJCCR) of Queen’s University, with Dr Shannon Beattie joining the team.

Read the full article – Ovarian cancer diagnostics company GenoME raises £300,000 in funding (irishtimes.com)